Lataa...
Changes in the gut microbiome and fermentation products concurrent with enhanced longevity in acarbose-treated mice
BACKGROUND: Treatment with the α-glucosidase inhibitor acarbose increases median lifespan by approximately 20% in male mice and 5% in females. This longevity extension differs from dietary restriction based on a number of features, including the relatively small effects on weight and the sex-specifi...
Tallennettuna:
| Julkaisussa: | BMC Microbiol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6567620/ https://ncbi.nlm.nih.gov/pubmed/31195972 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12866-019-1494-7 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|